Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Smolen, Josef S, Prof, Beaulieu, Andre, MD, Rubbert-Roth, Andrea, MD, Ramos-Remus, Cesar, Prof, Rovensky, Josef, Prof, Alecock, Emma, MSc, Woodworth, Thasia, MD, Alten, Rieke, MD
Published in The Lancet (British edition) (22.03.2008)
Published in The Lancet (British edition) (22.03.2008)
Get full text
Journal Article